CombiSep Appoints NanoChrom as West Coast Representative
News Dec 20, 2005
CombiSep, Inc. has recently appointed NanoChrom, LLC as its representative for the West Coast.
Mark McDonald, Chief Executive Officer of CombiSep, anticipates the relationship with NanoChrom saying, "I am extremely pleased that NanoChrom will be serving our western U.S. customers."
He adds, "Mr. Terry Ochsner, President of NanoChrom, has extensive sales and service experience in separation science instrumentation and has served in key leadership positions within Hitachi High Technologies America and Merck KGaA."
"Terry’s company will provide vital local representation in a very strategic geographical market for CombiSep’s CE-based life science solutions."
Mr. Terry Ochsner, President of NanoChrom, LLC said, "I believe that CombiSep’s parallel capillary electrophoresis technology has great potential in the life science marketplace, and I look forward to expanding the presence of CombiSep throughout the West Coast."
"I view CombiSep as a key addition to the companies NanoChrom represents in our quest to provide unique system solutions and services to the life science community."
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE